This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Korea Research Institute of Bioscience and Biotechnology. Active years: 2009-2011.
Company Filing History:
Years Active: 2009-2011
Title: Innovations in Cancer Diagnosis by Dae-Sil Lee
Introduction
Dae-Sil Lee is a prominent inventor based in Taejeon-si, South Korea. He has made significant contributions to the field of cancer diagnosis through his innovative methods and diagnostic kits. With a total of two patents to his name, Lee's work focuses on the critical area of tumorigenesis and metastasis.
Latest Patents
Lee's latest patents include a method for the diagnosis of cancers by measuring the changes of glycosylation of proteins related to tumorigenesis and metastasis. This invention also encompasses a diagnostic kit that utilizes this method. The approach is particularly effective for diagnosing various types of cancers, including colon cancer, stomach cancer, lung cancer, and liver cancer. By measuring the glycosylation changes in proteins, this method offers a sensitive and reliable means of cancer diagnosis.
Career Highlights
Dae-Sil Lee is affiliated with the Korea Research Institute of Bioscience and Biotechnology, where he continues to advance research in cancer diagnostics. His work has the potential to significantly impact the early detection and treatment of cancer, improving patient outcomes.
Collaborations
Lee has collaborated with notable colleagues, including Jeong Heon Ko and Soo Young Hwang, to further enhance the research and development of cancer diagnostic methods.
Conclusion
Dae-Sil Lee's innovative contributions to cancer diagnosis through his patented methods and kits represent a significant advancement in medical technology. His work not only showcases his expertise but also holds promise for improving cancer detection and treatment strategies in the future.